INTEGRA LIFESCIENCES HOLDINGS CORPORATION

Consensus Integra LifeSciences Holdings Corporation

Stocks

IART

US4579852082

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 16:00:00 2026-10-21 EDT			5-day change	1st Jan Change
11.84 ^USD	-11.18%		-10.13%	-4.67%

10-21	Integra LifeSciences Holdings Corporation, Q3 2026 Earnings Call, Oct 21, 2026
10-21	Integra LifeSciences Holdings Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2026	CI

Evolution of the Average Target: Integra LifeSciences Holdings Corporation

Evolution of the Target Price: Integra LifeSciences Holdings Corporation

Changes in Analyst Recommendations: Integra LifeSciences Holdings Corporation

4e5f5.ZKVKelVrANcSlgS8EvwS1tKKWHcokRw6tfA96xFv_9g.Bd96C20hMIhx53XvfshGlOTnASJw1mppzMNUkUc2tqgN7n5LGSAzlFjJMA~5d59aa7e636181973dbded258eea7790

Analysts' recommendations: Integra LifeSciences Holdings Corporation

10-14	Truist Securities Adjusts Integra LifeSciences Price Target to $15 From $19	MT
07-30	BMO Cuts Price Target on Integra LifeSciences Holdings to $18 From $19, Keeps Market Perform Rating	MT
07-28	UBS Initiates Coverage on Integra LifeSciences With Neutral Rating, $19 Price Target	MT
07-16	Truist Adjusts Price Target on Integra LifeSciences Holdings to $19 From $14, Maintains Hold Rating	MT
07-09	BMO Capital Initiates Integra LifeSciences at Market Perform With $19 Price Target	MT
06-18	Integra LifeSciences Shares Rise After Upgrade From Argus Research	MT
06-18	Argus Research Upgrades Integra LifeSciences to Buy From Hold, $25 Price Target	MT
05-28	Citigroup Upgrades Integra LifeSciences to Neutral From Sell, Adjusts Price Target to $16 From $11	MT
05-06	Truist Adjusts Price Target on Integra LifeSciences to $14 From $12, Maintains Hold Rating	MT
04-15	Truist Cuts Price Target on Integra LifeSciences Holdings to $12 From $13, Keeps Hold Rating	MT
01-12	Canaccord Genuity Initiates Coverage on Integra LifeSciences With Speculative Buy Rating, CA$9.25 Price Target	MT
25-07-31	Medtech firm Integra's Q2 revenue beats expectations	RE
25-05-13	Morgan Stanley Adjusts Price Target on Integra LifeSciences Holdings to $10 From $20, Maintains Equalweight Rating	MT
25-05-05	Top Midday Decliners	MT
25-04-11	Truist Cuts Price Target on Integra LifeSciences Holdings to $19 From $26, Keeps Hold Rating	MT
25-03-31	Argus Upgrades Integra LifeSciences to Buy From Hold, Price Target is $28	MT
24-11-05	Truist Raises Price Target on Integra LifeSciences Holdings to $26 From $21, Keeps Hold Rating	MT
24-10-14	Correction: Truist Trims Price Target on Integra LifeSciences Holdings to $21 From $26, Keeps Hold Rating	MT
24-10-14	Truist Raises Price Target on Integra LifeSciences Holdings to $26 From $21, Keeps Hold Rating	MT
24-10-07	BTIG Upgrades Integra LifeSciences Holdings to Neutral From Sell	MT
24-07-30	BTIG Downgrades Integra LifeSciences Holdings to Sell From Neutral, Price Target is $22	MT
24-07-30	Citigroup Downgrades Integra LifeSciences Holdings to Sell From Neutral, Adjusts Price Target to $23 From $30	MT
24-07-30	Analyst recommendations: 3M Company, Aon, Murphy USA, Skyworks, Tesla...
24-07-30	Truist Adjusts Price Target on Integra LifeSciences Holdings to $26 From $32 After 'Big' H2 Guide Cut, Maintains Hold Rating	MT
24-07-16	Truist Raises Price Target on Integra LifeSciences Holdings to $32 From $25, Maintains Hold Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	INTEGRA LIFESCIENCES HOLDINGS CORPORATION					+45.46%
	ABBOTT LABORATORIES					+18.95%
	STRYKER CORPORATION					+21.85%
	MEDTRONIC PLC					+12.45%
	ESSILORLUXOTTICA					+23.1%
	CENCORA, INC.					+8.42%
	HOYA CORPORATION					+15.54%
	BECTON, DICKINSON AND COMPANY					+0.63%
	IDEXX LABORATORIES, INC.					+26.11%
	ALCON INC.					+33.74%
	Average					+20.63%
	Weighted average by Cap.					+17.52%